Omamalin, Jean C.

HRN: 21-28-03  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/20/2022
CEFUROXIME 1.5GM (VIAL)
08/20/2022
08/20/2022
IV
1.5 G
Now
For Sta CS
Waiting Final Action 
08/20/2022
CEFUROXIME 1.5GM (VIAL)
08/20/2022
08/21/2022
IV
1.5gm
Q8 X 3 More Doses
S/P CS
Waiting Final Action 
08/20/2022
CEFUROXIME 500MG (TAB)
08/21/2022
08/28/2022
ORAL
500mg Tab
BID
S/P CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: